MHRA To Support UK Transitional QPs' Continuing Role Under EU Clinical Trials Regulation
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency is inviting all Qualified Persons for investigational medicinal products (IMP QPs) who have "transitional" status to apply for formal certification of their suitability to continue in the role.